Philip Morris International doubled its planned investment in a Colorado manufacturing campus to approximately $1.2 billion through 2028, expanding production capacity for Zyn nicotine pouches. The company originally announced a $600 million investment in 2024 to construct the Aurora facility, which officially opened on Monday and will serve domestic demand and export markets across Asia, Latin America and the Caribbean. Once fully operational, the plant is expected to generate approximately $550 million in annual economic activity and support 1,000 indirect jobs. The expansion follows the U.S. Food and Drug Administration's authorization of 20 Zyn nicotine-pouch products, allowing Philip Morris to market them as less harmful than cigarettes.
Philip Morris International IncPhilip Morris doubles Zyn investment to $1.2B, expanding production capacity and receiving FDA authorization for reduced-harm marketing.